SAN DIEGO--(BUSINESS WIRE)--DermTech International, Inc. (“DermTech”), a privately held molecular diagnostics company commercializing non-invasive gene expression tests for dermatology, announced today that it has completed validation testing of its proprietary Pigmented Lesion Assay (PLA) and completed California CLIA licensure of its San Diego laboratory facility.
Help employers find you! Check out all the jobs and post your resume.
